ATXS
Price
$8.39
Change
+$0.92 (+12.32%)
Updated
Oct 8, 04:59 PM (EDT)
Capitalization
433.98M
35 days until earnings call
TIL
Price
$20.52
Change
+$1.94 (+10.44%)
Updated
Oct 8, 04:59 PM (EDT)
Capitalization
125.43M
Interact to see
Advertisement

ATXS vs TIL

Header iconATXS vs TIL Comparison
Open Charts ATXS vs TILBanner chart's image
Astria Therapeutics
Price$8.39
Change+$0.92 (+12.32%)
Volume$5.46K
Capitalization433.98M
Instil Bio
Price$20.52
Change+$1.94 (+10.44%)
Volume$3.23K
Capitalization125.43M
ATXS vs TIL Comparison Chart in %
ATXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TIL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATXS vs. TIL commentary
Oct 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATXS is a StrongBuy and TIL is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 09, 2025
Stock price -- (ATXS: $7.47 vs. TIL: $18.58)
Brand notoriety: ATXS and TIL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATXS: 104% vs. TIL: 32%
Market capitalization -- ATXS: $433.98M vs. TIL: $125.43M
ATXS [@Biotechnology] is valued at $433.98M. TIL’s [@Biotechnology] market capitalization is $125.43M. The market cap for tickers in the [@Biotechnology] industry ranges from $105.19B to $0. The average market capitalization across the [@Biotechnology] industry is $2.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATXS’s FA Score shows that 0 FA rating(s) are green whileTIL’s FA Score has 1 green FA rating(s).

  • ATXS’s FA Score: 0 green, 5 red.
  • TIL’s FA Score: 1 green, 4 red.
According to our system of comparison, ATXS is a better buy in the long-term than TIL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATXS’s TA Score shows that 5 TA indicator(s) are bullish while TIL’s TA Score has 6 bullish TA indicator(s).

  • ATXS’s TA Score: 5 bullish, 5 bearish.
  • TIL’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, TIL is a better buy in the short-term than ATXS.

Price Growth

ATXS (@Biotechnology) experienced а +2.61% price change this week, while TIL (@Biotechnology) price change was +4.03% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.11%. For the same industry, the average monthly price growth was +19.03%, and the average quarterly price growth was +87.04%.

Reported Earning Dates

ATXS is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Biotechnology (+9.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATXS($434M) has a higher market cap than TIL($125M). TIL YTD gains are higher at: -2.672 vs. ATXS (-16.443). TIL has higher annual earnings (EBITDA): -75.66M vs. ATXS (-131.42M). ATXS has more cash in the bank: 259M vs. TIL (91.8M). ATXS has less debt than TIL: ATXS (4.77M) vs TIL (84.9M). ATXS (0) and TIL (0) have equivalent revenues.
ATXSTILATXS / TIL
Capitalization434M125M347%
EBITDA-131.42M-75.66M174%
Gain YTD-16.443-2.672615%
P/E RatioN/AN/A-
Revenue00-
Total Cash259M91.8M282%
Total Debt4.77M84.9M6%
FUNDAMENTALS RATINGS
ATXS vs TIL: Fundamental Ratings
ATXS
TIL
OUTLOOK RATING
1..100
73
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
12
Undervalued
PROFIT vs RISK RATING
1..100
10096
SMR RATING
1..100
9897
PRICE GROWTH RATING
1..100
4465
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
9081

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TIL's Valuation (12) in the Precious Metals industry is somewhat better than the same rating for ATXS (50) in the Biotechnology industry. This means that TIL’s stock grew somewhat faster than ATXS’s over the last 12 months.

TIL's Profit vs Risk Rating (96) in the Precious Metals industry is in the same range as ATXS (100) in the Biotechnology industry. This means that TIL’s stock grew similarly to ATXS’s over the last 12 months.

TIL's SMR Rating (97) in the Precious Metals industry is in the same range as ATXS (98) in the Biotechnology industry. This means that TIL’s stock grew similarly to ATXS’s over the last 12 months.

ATXS's Price Growth Rating (44) in the Biotechnology industry is in the same range as TIL (65) in the Precious Metals industry. This means that ATXS’s stock grew similarly to TIL’s over the last 12 months.

ATXS's P/E Growth Rating (100) in the Biotechnology industry is in the same range as TIL (100) in the Precious Metals industry. This means that ATXS’s stock grew similarly to TIL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATXSTIL
RSI
ODDS (%)
Bearish Trend 2 days ago
75%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 7 days ago
80%
Bullish Trend 2 days ago
84%
Declines
ODDS (%)
Bearish Trend 14 days ago
90%
Bearish Trend 14 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
83%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
ATXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TIL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AQEAX16.41N/A
N/A
Columbia Disciplined Core A
AIORX11.31N/A
N/A
American Century International Opps R
PKAIX15.33N/A
N/A
PIMCO RAE US Instl
MLPIX119.69N/A
N/A
ProFunds Mid Cap Value Inv
HFAEX16.75N/A
N/A
Hartford Schroders Intl Cntrrn Val C

ATXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATXS has been loosely correlated with XENE. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if ATXS jumps, then XENE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATXS
1D Price
Change %
ATXS100%
-2.86%
XENE - ATXS
52%
Loosely correlated
-0.99%
CRNX - ATXS
51%
Loosely correlated
+1.97%
COGT - ATXS
51%
Loosely correlated
-2.89%
DNLI - ATXS
51%
Loosely correlated
-2.10%
NRIX - ATXS
50%
Loosely correlated
-1.21%
More

TIL and

Correlation & Price change

A.I.dvisor indicates that over the last year, TIL has been loosely correlated with SMMT. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if TIL jumps, then SMMT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TIL
1D Price
Change %
TIL100%
+0.81%
SMMT - TIL
49%
Loosely correlated
+0.63%
BNTX - TIL
44%
Loosely correlated
+0.86%
STRO - TIL
41%
Loosely correlated
-3.25%
VTYX - TIL
39%
Loosely correlated
+6.70%
ATXS - TIL
39%
Loosely correlated
-2.86%
More